Philips ships 3-D DSA upgrade

Article

Philips Medical Systems of Shelton, CT, has begun shipping Integris 3D RA, a new option for the Integris V5000 line of angiography systems that enables clinicians to reconstruct rotational angiography exams into 3-D images. Philips debuted the technology

Philips Medical Systems of Shelton, CT, has begun shipping Integris 3D RA, a new option for the Integris V5000 line of angiography systems that enables clinicians to reconstruct rotational angiography exams into 3-D images. Philips debuted the technology at last year’s RSNA meeting as a separate workstation, but since then has decided to make it available as an option on the V5000 console.

Philips believes that Integris 3D RA will prove useful in neurointerventional procedures by giving clinicians more accurate views of neurological anatomy, such as the size and shape of a brain aneurysm. The software is capable of reconstructing the first 3-D image in six minutes, with subsequent reconstructions taking from 20 seconds to 10 minutes, depending on the size of the data set.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.